NYSE:SGFY
Delisted
Signify Health, Inc. Stock News
$30.49
+0 (+0%)
At Close: Jun 27, 2023
CVS CEO talks integration of Oak Street Health and Signify
08:06pm, Tuesday, 09'th Jan 2024
CVS CEO Karen Lynch joins 'Mad Money' host Jim Cramer to talk consumer behavior, weight loss drugs, store closures and more.
Is it time to buy this market-beaten growth stock?
05:31am, Wednesday, 29'th Nov 2023
Investing is a complex game, but the aim is simple: Profit. Despite there being numerous avenues through which this objective can be achieved, many concentrate on short-term price movement and growth.
Strength Seen in Signify (SGFY): Can Its 5.8% Jump Turn into More Strength?
03:52am, Tuesday, 28'th Mar 2023
Signify (SGFY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
This Boring Business Could Be a Secret Weapon to Beat the Market
06:45am, Friday, 24'th Mar 2023
CVS has piled on debt to reinvent its business. The stock's been sold off in this high-interest-rate environment.
These Are the Top 10 Holdings of George Soros
10:56pm, Monday, 20'th Mar 2023
George Soros is considered to be among the most successful investors of all time. He managed client money from 1969 to 2011 and his Quantum Fund gave an average annual return of 30% from 1970 to 2000.
3 Growth Stocks That Could Disrupt the Healthcare Industry
03:29pm, Monday, 13'th Mar 2023
Healthcare growth stocks are often sought out by investors looking for market disruptors. That's because these stocks can potentially deliver high revenue growth, earnings, and stock price.
Time to Buy CVS Stock Before Crucial Q4 Earnings?
07:34pm, Monday, 06'th Feb 2023
Trading near its 52-week lows and 23% from its highs, investors will be paying close attention to CVS Health's (CVS) fourth-quarter earnings on February 8.
Mergers and Acquisitions in 2023 Off To A Strong Start
08:17am, Friday, 27'th Jan 2023
Mergers and acquisitions are a normal part of business, but 2023 has already presented many opportunities across the biotech industry. The M&A surge seems to be driven by two major transactions: the $
Time to Buy CVS or Oak Street Health Stock on Potential Acquisition?
09:04pm, Friday, 13'th Jan 2023
News of CVS Health (CVS) potentially acquiring Oak Street Health (OHS) for $10 billion broke this week and highlighted what could be another lucrative acquisition in 2023.
How 2022's Biggest Healthcare Gainers Could Fare In 2023
09:30am, Friday, 06'th Jan 2023
Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023
Checking Signify Health Before The CVS Transaction
04:02pm, Wednesday, 21'st Dec 2022
The planned CVS acquisition of SGFY is just around the corner, stated for completion in H1 FY23. SGFY is well positioned to hit top-bottom line growth targets; therefore, there's good accretion potent
The Top (and Bottom) Five Stocks of 2022
09:45am, Tuesday, 06'th Dec 2022
Occidental Petroleum, Constellation Energy, Antero Resources, Texas Pacific Land, and Signify Health are the top stocks of the year. The bottom five are Affirm Holdings, AppLovin, Wayfair, Coinbase Gl
These Were The Five Best And Worst Performing Mid-Cap Stocks In Q3 2022
09:21pm, Monday, 24'th Oct 2022
Mid-cap companies are those that fall between small and large cap companies. Thus, they are more stable than small-cap companies and, at the same time, offer higher growth opportunities than large-cap
The Top 5 Stocks Cathie Wood Bought and Sold This Week
05:10pm, Friday, 21'st Oct 2022
It has been another volatile week for Cathie Wood's flagship exchange-traded fund (ETF), the ARK Innovation ETF (NYSEARCA: ARKK ). Shares of ARKK recently hit a five-year low and 52-week low of $33.74
Cathie Wood Cuts $32M From Healthcare Company In Which Amazon Is Reportedly Interested
02:19am, Wednesday, 21'st Sep 2022 Benzinga
Cathie Wood-led Ark Investment Management on Tuesday sold 1,102,797 shares in Signify Health Inc. (NYSE: SGFY), valued at $32.3 million, via two of its key exchange-traded funds.
The firm sold 670